Education
About Us
Working with TipRanks
Follow Us
AC Immune SA (ACIU)
NASDAQ:ACIU
Total Valuation
AC Immune SA has a market cap or net worth of $154.35M. The enterprise value is $197.72M.
Market Cap$154.35M
Enterprise Value$197.72M
Share Statistics
AC Immune SA has 98.94M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98.94M
Owned by Insiders
Owned by Instutions21.69%
Financial Efficiency
AC Immune SA’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -39.95%.
Return on Equity (ROE)-45.35%
Return on Assets (ROA)-22.05%
Return on Invested Capital (ROIC)-39.95%
Return on Capital Employed (ROCE)-40.27%
Revenue Per Employee$205,330.827
Profits Per Employee-$382,827.068
Employee Count133
Asset Turnover0.12
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AC Immune SA is -5.30. AC Immune SA’s PEG ratio is 0.19.
PE Ratio-5.30
PS Ratio9.88
PB Ratio2.40
Price to Fair Value2.40
Price to FCF4.13
Price to Operating Cash Flow4.10
PEG Ratio0.19
Income Statement
In the last 12 months, AC Immune SA had revenue of $27.31M and earned -$50.92M in profits. Earnings per share was -$0.50.
Revenue$27.31M
Gross Profit-$4.99M
Operating Income-$52.38M
Pretax Income-$50.91M
Net Income-$50.92M
EBITDA-50.23M
Earnings Per Share (EPS)-0.50
Cash Flow
In the last 12 months, operating cash flow was $65.84M and capital expenditures -$576.00K, giving a free cash flow of $65.27M billion.
Operating Cash Flow$65.84M
Free Cash Flow$65.27M
Free Cash Flow per Share$0.66
Dividends & Yields
AC Immune SA pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield24.19%
Earnings Yield-18.88%
Stock Price Statistics
Beta1.27
52-Week Price Change-39.68%
50-Day Moving Average2.28
200-Day Moving Average3.01
Relative Strength Index (RSI)26.64
Average Volume (3m)207.65K
Important Dates
AC Immune SA upcoming earnings date is Apr 24, 2025, TBA.
Last Earnings DateMar 13, 2025
Next Earnings DateApr 24, 2025
Ex-Dividend Date―
Financial Position
AC Immune SA as a current ratio of 1.71, with Debt / Equity ratio of 0.05
Current Ratio1.71
Quick Ratio1.71
Debt to Market Cap0.00
Net Debt to EBITDA0.63
Interest Coverage Ratio-393.82
Taxes
In the past 12 months, AC Immune SA has paid $39.00K in taxes.
Income Tax$39.00K
Effective Tax Rate>-0.01%
Enterprise Valuation
AC Immune SA EV to EBITDA ratio is -4.91, with an EV/FCF ratio of 3.66.
EV to Sales8.75
EV to EBITDA-4.91
EV to Free Cash Flow3.66
EV to Operating Cash Flow3.63
Balance Sheet
AC Immune SA has $165.49M in cash and marketable securities with $5.43M in debt, giving a net cash position of -$160.06M billion.
Cash & Marketable Securities$165.49M
Total Debt$5.43M
Net Cash-$160.06M
Net Cash Per Share-$1.62
Tangible Book Value Per Share$0.56
Margins
Gross margin is 100.00%, with operating margin of -191.80%, and net profit margin of -186.44%.
Gross Margin100.00%
Operating Margin-191.80%
Pretax Margin-186.43%
Net Profit Margin-186.44%
EBITDA Margin-178.03%
EBIT Margin-185.95%
Analyst Forecast
The average price target for AC Immune SA is $16.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$16.00
Price Target Upside925.64%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast88.63%
EPS Growth Forecast18.78%